nodes	percent_of_prediction	percent_of_DWPC	metapath
Methotrexate—ABCC2—bile canaliculus—sclerosing cholangitis	0.189	0.302	CbGeAlD
Methotrexate—ABCC3—bile duct—sclerosing cholangitis	0.0737	0.118	CbGeAlD
Methotrexate—ABCC11—ABC-family proteins mediated transport—CFTR—sclerosing cholangitis	0.0632	0.168	CbGpPWpGaD
Methotrexate—ABCC2—bile duct—sclerosing cholangitis	0.0589	0.0944	CbGeAlD
Methotrexate—ABCC2—bile—sclerosing cholangitis	0.0453	0.0725	CbGeAlD
Methotrexate—ABCC10—ABC-family proteins mediated transport—CFTR—sclerosing cholangitis	0.0419	0.111	CbGpPWpGaD
Methotrexate—AOX1—Effects of Nitric Oxide—NOS2—sclerosing cholangitis	0.0171	0.0454	CbGpPWpGaD
Methotrexate—ABCC3—ABC-family proteins mediated transport—CFTR—sclerosing cholangitis	0.0162	0.0432	CbGpPWpGaD
Methotrexate—AOX1—gall bladder—sclerosing cholangitis	0.0161	0.0258	CbGeAlD
Methotrexate—ABCC3—gall bladder—sclerosing cholangitis	0.0157	0.0252	CbGeAlD
Methotrexate—GGH—pancreas—sclerosing cholangitis	0.0153	0.0245	CbGeAlD
Methotrexate—ABCC4—ABC-family proteins mediated transport—CFTR—sclerosing cholangitis	0.0152	0.0406	CbGpPWpGaD
Methotrexate—ABCC11—liver—sclerosing cholangitis	0.0141	0.0225	CbGeAlD
Methotrexate—ABCC3—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.0136	0.0361	CbGpPWpGaD
Methotrexate—ALB—gall bladder—sclerosing cholangitis	0.0134	0.0215	CbGeAlD
Methotrexate—ATIC—pancreas—sclerosing cholangitis	0.013	0.0209	CbGeAlD
Methotrexate—SLC19A1—liver—sclerosing cholangitis	0.0129	0.0206	CbGeAlD
Methotrexate—ABCC2—ABC-family proteins mediated transport—CFTR—sclerosing cholangitis	0.0129	0.0342	CbGpPWpGaD
Methotrexate—ABCC1—ABC-family proteins mediated transport—CFTR—sclerosing cholangitis	0.0127	0.0338	CbGpPWpGaD
Methotrexate—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.0108	0.0286	CbGpPWpGaD
Methotrexate—SLC46A1—liver—sclerosing cholangitis	0.00991	0.0159	CbGeAlD
Methotrexate—GGH—liver—sclerosing cholangitis	0.00975	0.0156	CbGeAlD
Methotrexate—SLCO4C1—liver—sclerosing cholangitis	0.00865	0.0138	CbGeAlD
Methotrexate—FPGS—liver—sclerosing cholangitis	0.00857	0.0137	CbGeAlD
Methotrexate—SLCO1B3—liver—sclerosing cholangitis	0.0084	0.0135	CbGeAlD
Methotrexate—ATIC—liver—sclerosing cholangitis	0.00829	0.0133	CbGeAlD
Methotrexate—AOX1—pancreas—sclerosing cholangitis	0.00741	0.0119	CbGeAlD
Methotrexate—SLC22A11—liver—sclerosing cholangitis	0.00669	0.0107	CbGeAlD
Methotrexate—ABCC11—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.00661	0.0176	CbGpPWpGaD
Methotrexate—SLC22A7—liver—sclerosing cholangitis	0.00653	0.0105	CbGeAlD
Methotrexate—ABCC1—Synthesis of Leukotrienes (LT) and Eoxins (EX)—GGT1—sclerosing cholangitis	0.00641	0.0171	CbGpPWpGaD
Methotrexate—MTHFR—liver—sclerosing cholangitis	0.00616	0.00987	CbGeAlD
Methotrexate—SLCO3A1—liver—sclerosing cholangitis	0.00606	0.00971	CbGeAlD
Methotrexate—ABCB1—ABC-family proteins mediated transport—CFTR—sclerosing cholangitis	0.00605	0.0161	CbGpPWpGaD
Methotrexate—ABCC4—pancreas—sclerosing cholangitis	0.00598	0.00958	CbGeAlD
Methotrexate—TYMS—liver—sclerosing cholangitis	0.00562	0.009	CbGeAlD
Methotrexate—DHFR—liver—sclerosing cholangitis	0.00557	0.00891	CbGeAlD
Methotrexate—PGD—liver—sclerosing cholangitis	0.00535	0.00857	CbGeAlD
Methotrexate—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.00506	0.0135	CbGpPWpGaD
Methotrexate—SLC16A1—liver—sclerosing cholangitis	0.005	0.008	CbGeAlD
Methotrexate—SLCO1B1—liver—sclerosing cholangitis	0.00486	0.00778	CbGeAlD
Methotrexate—AOX1—liver—sclerosing cholangitis	0.00471	0.00755	CbGeAlD
Methotrexate—ABCC3—liver—sclerosing cholangitis	0.00461	0.00738	CbGeAlD
Methotrexate—ABCC10—liver—sclerosing cholangitis	0.00459	0.00735	CbGeAlD
Methotrexate—TYMS—Integrated Pancreatic Cancer Pathway—MST1—sclerosing cholangitis	0.00438	0.0117	CbGpPWpGaD
Methotrexate—ABCC10—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.00438	0.0116	CbGpPWpGaD
Methotrexate—SLC46A1—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.00438	0.0116	CbGpPWpGaD
Methotrexate—SLCO3A1—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.00415	0.011	CbGpPWpGaD
Methotrexate—PGD—NRF2 pathway—GGT1—sclerosing cholangitis	0.0041	0.0109	CbGpPWpGaD
Methotrexate—MTHFR—Selenium Micronutrient Network—GGT1—sclerosing cholangitis	0.00405	0.0108	CbGpPWpGaD
Methotrexate—SLCO4C1—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.00396	0.0105	CbGpPWpGaD
Methotrexate—SLCO1A2—liver—sclerosing cholangitis	0.00395	0.00633	CbGeAlD
Methotrexate—ALB—liver—sclerosing cholangitis	0.00393	0.0063	CbGeAlD
Methotrexate—ABCC4—liver—sclerosing cholangitis	0.00381	0.0061	CbGeAlD
Methotrexate—ABCC2—liver—sclerosing cholangitis	0.00368	0.0059	CbGeAlD
Methotrexate—SLCO1C1—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.00332	0.00883	CbGpPWpGaD
Methotrexate—ABCC1—liver—sclerosing cholangitis	0.00325	0.0052	CbGeAlD
Methotrexate—ABCC1—Arachidonic acid metabolism—GGT1—sclerosing cholangitis	0.0032	0.00853	CbGpPWpGaD
Methotrexate—PGD—Carbohydrate metabolism—GOT2—sclerosing cholangitis	0.003	0.00799	CbGpPWpGaD
Methotrexate—ABCG2—liver—sclerosing cholangitis	0.00269	0.0043	CbGeAlD
Methotrexate—PGD—Carbohydrate metabolism—GOT1—sclerosing cholangitis	0.00259	0.0069	CbGpPWpGaD
Methotrexate—SLC19A1—Metabolism—ABCB4—sclerosing cholangitis	0.00247	0.00659	CbGpPWpGaD
Methotrexate—SLC22A11—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.00218	0.0058	CbGpPWpGaD
Methotrexate—SLC16A1—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.00214	0.00569	CbGpPWpGaD
Methotrexate—ATIC—Metabolism—ABCB4—sclerosing cholangitis	0.0021	0.0056	CbGpPWpGaD
Methotrexate—FPGS—Metabolism—ABCB4—sclerosing cholangitis	0.0021	0.0056	CbGpPWpGaD
Methotrexate—ABCB1—pancreas—sclerosing cholangitis	0.00208	0.00333	CbGeAlD
Methotrexate—SLC22A7—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.00198	0.00526	CbGpPWpGaD
Methotrexate—SLCO1B3—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.00188	0.005	CbGpPWpGaD
Methotrexate—ABCC3—NRF2 pathway—GGT1—sclerosing cholangitis	0.00173	0.00462	CbGpPWpGaD
Methotrexate—ABCC3—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.00169	0.00451	CbGpPWpGaD
Methotrexate—SLC22A8—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.00166	0.00442	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—ABCB4—sclerosing cholangitis	0.00164	0.00436	CbGpPWpGaD
Methotrexate—ABCC4—NRF2 pathway—GGT1—sclerosing cholangitis	0.00163	0.00434	CbGpPWpGaD
Methotrexate—ABCC4—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.00159	0.00424	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.00158	0.0042	CbGpPWpGaD
Methotrexate—ABCG2—HIF-1-alpha transcription factor network—HIF1A—sclerosing cholangitis	0.00157	0.00418	CbGpPWpGaD
Methotrexate—PGD—Metabolism—ABCB4—sclerosing cholangitis	0.0015	0.00399	CbGpPWpGaD
Methotrexate—SLCO1A2—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.00148	0.00393	CbGpPWpGaD
Methotrexate—ABCG2—HIF-1-alpha transcription factor network—NOS2—sclerosing cholangitis	0.00143	0.0038	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.00142	0.00379	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—GOT2—sclerosing cholangitis	0.0014	0.00374	CbGpPWpGaD
Methotrexate—SLC22A6—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.00139	0.00369	CbGpPWpGaD
Methotrexate—ABCC2—NRF2 pathway—GGT1—sclerosing cholangitis	0.00138	0.00366	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—MST1—sclerosing cholangitis	0.00135	0.0036	CbGpPWpGaD
Methotrexate—ABCC2—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.00134	0.00358	CbGpPWpGaD
Methotrexate—ABCC1—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.00133	0.00354	CbGpPWpGaD
Methotrexate—ABCB1—liver—sclerosing cholangitis	0.00132	0.00212	CbGeAlD
Methotrexate—SLCO1B1—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.00126	0.00336	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.00124	0.0033	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—GOT1—sclerosing cholangitis	0.00121	0.00322	CbGpPWpGaD
Methotrexate—FPGS—Disease—GOT2—sclerosing cholangitis	0.00119	0.00318	CbGpPWpGaD
Methotrexate—SLC19A1—Metabolism—GOT2—sclerosing cholangitis	0.00118	0.00313	CbGpPWpGaD
Methotrexate—ABCG2—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.00117	0.00311	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.00112	0.00297	CbGpPWpGaD
Methotrexate—ALB—Selenium Micronutrient Network—GGT1—sclerosing cholangitis	0.00111	0.00295	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.00106	0.00282	CbGpPWpGaD
Methotrexate—FPGS—Disease—GOT1—sclerosing cholangitis	0.00103	0.00274	CbGpPWpGaD
Methotrexate—TYMS—Circadian rythm related genes—NOS2—sclerosing cholangitis	0.00103	0.00273	CbGpPWpGaD
Methotrexate—SLC19A1—Metabolism—GGT1—sclerosing cholangitis	0.00101	0.0027	CbGpPWpGaD
Methotrexate—SLC19A1—Metabolism—GOT1—sclerosing cholangitis	0.00101	0.0027	CbGpPWpGaD
Methotrexate—FPGS—Metabolism—GOT2—sclerosing cholangitis	0.000999	0.00266	CbGpPWpGaD
Methotrexate—ATIC—Metabolism—GOT2—sclerosing cholangitis	0.000999	0.00266	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—ABCB4—sclerosing cholangitis	0.000989	0.00263	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—ABCB4—sclerosing cholangitis	0.000966	0.00257	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—GOT2—sclerosing cholangitis	0.00093	0.00247	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—ABCB4—sclerosing cholangitis	0.000879	0.00234	CbGpPWpGaD
Methotrexate—FPGS—Metabolism—GOT1—sclerosing cholangitis	0.000863	0.0023	CbGpPWpGaD
Methotrexate—ATIC—Metabolism—GOT1—sclerosing cholangitis	0.000863	0.0023	CbGpPWpGaD
Methotrexate—ATIC—Metabolism—GGT1—sclerosing cholangitis	0.000863	0.0023	CbGpPWpGaD
Methotrexate—FPGS—Metabolism—GGT1—sclerosing cholangitis	0.000863	0.0023	CbGpPWpGaD
Methotrexate—PGD—Disease—GOT2—sclerosing cholangitis	0.00085	0.00226	CbGpPWpGaD
Methotrexate—ABCB1—HIF-1-alpha transcription factor network—HIF1A—sclerosing cholangitis	0.000849	0.00226	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—HIF1A—sclerosing cholangitis	0.000843	0.00224	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—GOT1—sclerosing cholangitis	0.000802	0.00214	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—ABCB4—sclerosing cholangitis	0.0008	0.00213	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—GOT2—sclerosing cholangitis	0.000778	0.00207	CbGpPWpGaD
Methotrexate—ABCB1—HIF-1-alpha transcription factor network—NOS2—sclerosing cholangitis	0.000772	0.00206	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—ABCB4—sclerosing cholangitis	0.000767	0.00204	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—NOS2—sclerosing cholangitis	0.000767	0.00204	CbGpPWpGaD
Methotrexate—PGD—Disease—GOT1—sclerosing cholangitis	0.000734	0.00195	CbGpPWpGaD
Methotrexate—ALB—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.000721	0.00192	CbGpPWpGaD
Methotrexate—FPGS—Disease—HIF1A—sclerosing cholangitis	0.000717	0.00191	CbGpPWpGaD
Methotrexate—PGD—Metabolism—GOT2—sclerosing cholangitis	0.000712	0.0019	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—ABCB4—sclerosing cholangitis	0.000703	0.00187	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—GGT1—sclerosing cholangitis	0.000672	0.00179	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—GOT1—sclerosing cholangitis	0.000672	0.00179	CbGpPWpGaD
Methotrexate—FPGS—Disease—NOS2—sclerosing cholangitis	0.000652	0.00174	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.000648	0.00172	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—ABCB4—sclerosing cholangitis	0.000635	0.00169	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.000632	0.00168	CbGpPWpGaD
Methotrexate—PGD—Metabolism—GOT1—sclerosing cholangitis	0.000615	0.00164	CbGpPWpGaD
Methotrexate—PGD—Metabolism—GGT1—sclerosing cholangitis	0.000615	0.00164	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.000606	0.00161	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.000584	0.00156	CbGpPWpGaD
Methotrexate—MTHFR—Disease—GOT2—sclerosing cholangitis	0.000561	0.00149	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—HIF1A—sclerosing cholangitis	0.000558	0.00149	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—ABCB4—sclerosing cholangitis	0.000553	0.00147	CbGpPWpGaD
Methotrexate—AOX1—Disease—GOT2—sclerosing cholangitis	0.000548	0.00146	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—NOS2—sclerosing cholangitis	0.000512	0.00136	CbGpPWpGaD
Methotrexate—PGD—Disease—HIF1A—sclerosing cholangitis	0.000511	0.00136	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.000509	0.00135	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—NOS2—sclerosing cholangitis	0.000508	0.00135	CbGpPWpGaD
Methotrexate—DHFR—Disease—GOT2—sclerosing cholangitis	0.000498	0.00133	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—ABCB4—sclerosing cholangitis	0.000497	0.00132	CbGpPWpGaD
Methotrexate—MTHFR—Disease—GOT1—sclerosing cholangitis	0.000484	0.00129	CbGpPWpGaD
Methotrexate—AOX1—Disease—GOT1—sclerosing cholangitis	0.000473	0.00126	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—ABCB4—sclerosing cholangitis	0.000473	0.00126	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—GOT2—sclerosing cholangitis	0.00047	0.00125	CbGpPWpGaD
Methotrexate—PGD—Disease—NOS2—sclerosing cholangitis	0.000464	0.00124	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—GOT2—sclerosing cholangitis	0.000459	0.00122	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.000458	0.00122	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—ABCB4—sclerosing cholangitis	0.000438	0.00116	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.000435	0.00116	CbGpPWpGaD
Methotrexate—DHFR—Disease—GOT1—sclerosing cholangitis	0.00043	0.00115	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—GOT2—sclerosing cholangitis	0.000417	0.00111	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—GOT1—sclerosing cholangitis	0.000405	0.00108	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—GGT1—sclerosing cholangitis	0.000405	0.00108	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—GGT1—sclerosing cholangitis	0.000396	0.00105	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—GOT1—sclerosing cholangitis	0.000396	0.00105	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—NOS2—sclerosing cholangitis	0.000382	0.00102	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—GOT2—sclerosing cholangitis	0.00038	0.00101	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—GOT2—sclerosing cholangitis	0.000364	0.00097	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—GGT1—sclerosing cholangitis	0.00036	0.000959	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—GOT1—sclerosing cholangitis	0.00036	0.000959	CbGpPWpGaD
Methotrexate—MTHFR—Disease—HIF1A—sclerosing cholangitis	0.000337	0.000897	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—GOT2—sclerosing cholangitis	0.000334	0.000889	CbGpPWpGaD
Methotrexate—AOX1—Disease—HIF1A—sclerosing cholangitis	0.000329	0.000876	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—GGT1—sclerosing cholangitis	0.000328	0.000874	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—GOT1—sclerosing cholangitis	0.000328	0.000874	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—GGT1—sclerosing cholangitis	0.000314	0.000837	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—GOT1—sclerosing cholangitis	0.000314	0.000837	CbGpPWpGaD
Methotrexate—MTHFR—Disease—NOS2—sclerosing cholangitis	0.000306	0.000816	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—GOT2—sclerosing cholangitis	0.000301	0.000803	CbGpPWpGaD
Methotrexate—DHFR—Disease—HIF1A—sclerosing cholangitis	0.000299	0.000797	CbGpPWpGaD
Methotrexate—AOX1—Disease—NOS2—sclerosing cholangitis	0.000299	0.000797	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—GOT1—sclerosing cholangitis	0.000288	0.000768	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—GGT1—sclerosing cholangitis	0.000288	0.000768	CbGpPWpGaD
Methotrexate—ABCC1—Disease—GOT2—sclerosing cholangitis	0.000282	0.000751	CbGpPWpGaD
Methotrexate—DHFR—Disease—NOS2—sclerosing cholangitis	0.000272	0.000725	CbGpPWpGaD
Methotrexate—ALB—Metabolism—ABCB4—sclerosing cholangitis	0.00027	0.000719	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—GOT2—sclerosing cholangitis	0.000263	0.000699	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—GOT1—sclerosing cholangitis	0.00026	0.000693	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—GGT1—sclerosing cholangitis	0.00026	0.000693	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.000249	0.000662	CbGpPWpGaD
Methotrexate—ABCC1—Disease—GOT1—sclerosing cholangitis	0.000243	0.000648	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—ABCB4—sclerosing cholangitis	0.000237	0.00063	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—GOT2—sclerosing cholangitis	0.000236	0.000629	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—GOT1—sclerosing cholangitis	0.000227	0.000603	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—GGT1—sclerosing cholangitis	0.000227	0.000603	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—GOT2—sclerosing cholangitis	0.000224	0.000598	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—GOT2—sclerosing cholangitis	0.000208	0.000553	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—GGT1—sclerosing cholangitis	0.000204	0.000543	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—GOT1—sclerosing cholangitis	0.000204	0.000543	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—GGT1—sclerosing cholangitis	0.000194	0.000516	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—GOT1—sclerosing cholangitis	0.000194	0.000516	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—GGT1—sclerosing cholangitis	0.000179	0.000478	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—GOT1—sclerosing cholangitis	0.000179	0.000478	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—NOS2—sclerosing cholangitis	0.000173	0.00046	CbGpPWpGaD
Methotrexate—ABCC1—Disease—HIF1A—sclerosing cholangitis	0.000169	0.000451	CbGpPWpGaD
Methotrexate—ABCC1—Disease—NOS2—sclerosing cholangitis	0.000154	0.00041	CbGpPWpGaD
Methotrexate—ALB—Metabolism—GOT2—sclerosing cholangitis	0.000128	0.000341	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—GOT2—sclerosing cholangitis	0.000112	0.000299	CbGpPWpGaD
Methotrexate—ALB—Metabolism—GGT1—sclerosing cholangitis	0.000111	0.000295	CbGpPWpGaD
Methotrexate—ALB—Metabolism—GOT1—sclerosing cholangitis	0.000111	0.000295	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—GGT1—sclerosing cholangitis	9.7e-05	0.000258	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—GOT1—sclerosing cholangitis	9.7e-05	0.000258	CbGpPWpGaD
